Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hinge Health Inc. Class A Common Stock (HNGE) vs YieldMax MSTR Option Income Strategy ETF (MSTY) Price & Performance

Hinge Health Inc. Class A Common StockTrade
YieldMax MSTR Option Income Strategy ETFTrade

Price performance (Past 24H)

Key statistics

Hinge Health Inc. Class A Common Stock vs YieldMax MSTR Option Income Strategy ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while YieldMax MSTR Option Income Strategy ETF trades at $14.15 (market cap $1.14B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 7.4× YieldMax MSTR Option Income Strategy ETF's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and YieldMax MSTR Option Income Strategy ETF for 31 Days on average.

HNGEMSTY
Market Cap
$8.47B$1.14B
Volume
1,624,5263,125,982
Sector
HealthIncome / Options Overlay
52-Week High
$105.14$63.60
52-Week Low
$31.17$11.55
Typical Hold Time
0 Days31 Days
Enterprise Value
$8.09B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hinge Health Inc. Class A Common Stock

Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.

The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.

YieldMax MSTR Option Income Strategy ETF

MSTY trades at $15.52, down 0.13% on the day, with a bearish technical outlook as moving averages signal selling pressure. The ETF's high distribution rate, exceeding 100% annualized, is a key feature but has coincided with significant NAV erosion, as noted in recent financial media. Recent weekly dividend announcements from YieldMax highlight the income focus, but underlying asset volatility remains a concern.

The outlook is cautious; while the high yield is attractive for income-seeking investors, it comes with substantial risk of principal depletion. Analyst sentiment is mixed, balancing the tactical income opportunity against structural concerns about the fund's long-term sustainability in volatile markets.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HNGE
100% Buy0% Sell
Avg holding period · 0 Days
MSTY
95% Buy5% Sell
Avg holding period · 31 Days

About Hinge Health Inc. Class A Common Stock

Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.

Read more on HNGE →

About YieldMax MSTR Option Income Strategy ETF

MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.

Read more on MSTY →